Thomas Tu - 27 Jul 2021 Form 4 Insider Report for Inari Medical, Inc.

Role: Chief Medical Officer
Signature: /s/ Angela Ahmad, attorney-in-fact for Thomas Tu
Issuer symbol: N/A
Transactions as of: 27 Jul 2021
Net transactions value: -$418,737
Form type: 4
Filing time: 28 Jul 2021, 13:28:50 UTC
Previous filing: 07 Jul 2021
Next filing: 30 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NARI	Common Stock	Options Exercise	$2,285	+5,000	+10%	$0.4570^*	53,852	27 Jul 2021	Direct
transaction	NARI	Common Stock	Sale	$123,374	-1,483	-2.8%	$83.19	52,369	27 Jul 2021	Direct	F1, F2
transaction	NARI	Common Stock	Sale	$134,271	-1,600	-3.1%	$83.92	50,769	27 Jul 2021	Direct	F1, F3
transaction	NARI	Common Stock	Sale	$154,802	-1,817	-3.6%	$85.20	48,952	27 Jul 2021	Direct	F1, F4
transaction	NARI	Common Stock	Sale	$8,575	-100	-0.2%	$85.75	48,852	27 Jul 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NARI	Stock Option	Options Exercise	$0	-5,000	-2.1%	$0.000000	230,584	27 Jul 2021	Common Stock	5,000	$0.4570	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2020.
F2	This transaction was executed in multiple trades at prices ranging from $82.65 to $83.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $83.72 to $84.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	This transaction was executed in multiple trades at prices ranging from $84.73 to $85.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5	Option vested with respected with 25% of the underline shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment there after.